Bethel, Connecticut, USA
Trajan Scientific and Medical (Trajan) today announced the acquisition of the business of Soltec Inc, located in Bethel CT, USA.
Soltec was founded in 1982 by Jim Berray and grew to become one of the most respected manufacturers of septa and caps for use in chromatography workflow solutions. Sadly Jim passed away in 2017, but his team continued their dedicated work, building on their solid foundation of expertise in silicone chemistry, materials technology and production automation.
Chief Executive Officer of Trajan, Mr Stephen Tomisich, comments, “We are pleased to welcome the Soltec team into the Trajan family and intend to continue operating from the current site. Bringing Soltec into the Trajan Group will complement the widening capability of Trajan in sample handling. From collection point to workflow transport, we see ensuring the integrity of the sample as integral to ensuring quality analytical outcomes. The purity and inertness of the Soltec range of capped septa is an important addition to deliver on our pre-analytical strategy.
Chief Scientific Officer of Trajan, Dr Andrew Gooley adds, “Soltec highly complements Trajan’s existing chromatography portfolio and we look forward to building the product range and investing in new technologies to address the needs of emerging analytical challenges.”
The acquisition of Soltec solidifies Trajan’s expanding manufacturing footprint, with established sites in Penang (Malaysia), Melbourne (Victoria, Australia), San Diego (CA, USA), Raleigh (NC, USA) and Austin (TX, USA), producing products and technologies that service the Global Analytical and Life Science markets.
Trajan continues to deliver to their vision developing and providing integrated scientific measurement devices to enrich the wellbeing of communities through science, with a robust acquisition history including LEAP Technologies Inc (2016), Epic Extrusion (2016), HD Scientific (2014), SGE Analytical Science (2013) and Grale Scientific (2011).
Press release [PDF]
Media contact information
Trajan Scientific and Medical
Tel: +44 (0) 1244 403 100
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.
Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.